November 2, 2023 10:47 AM EDT
News Briefing

Pro­tag­o­nist's $50M mile­stone; Swiss biotech rais­es $27M; Kymera halts a PhI

Jaimy Lee

Deputy Editor

Plus, news from CEPI and Pro­JenX:

Pro­tag­o­nist Ther­a­peu­tics records a $50M mile­stone: The com­pa­ny said Wednes­day that it’s get­ting a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times